Navigation Links
Essilor : 2007 Results
Date:3/6/2008

nd as a percentage of revenue

Change in Reported Like-for-like Effect of Currency effect

contribution from changes in

operations(1) in 2007 scope of

consolidation

In millions of euros 44.8 57.6 7.2 (20.0)

In % +9.3% +11.9% + 1.5% - 4.1%

(1) Operating profit before share-based payments, restructuring costs and other non-recurring items, and goodwill impairment.

In all, contribution from operations increased 9.3% to EUR527.4 million in 2007, while the contribution margin was 0.2 points higher at 18.1% of revenue.

Other Income and Expenses from Operations

Other income and expenses from operations represented a net expense of EUR22.8 million in 2007, virtually unchanged from the previous year and amounting to 0.8% of revenue. These expense items comprised:

- Compensation costs on share-based payments (EUR20.2 million), reflecting stock option and performance share costs (EUR16.2 million) and costs related to the share price discounts and matching contributions to the Employee Stock Ownership Plan (EUR4 million).

- Goodwill impairment losses (EUR2.3 million).

- Restructuring costs on the conversion of part of the Mexican plant into a laboratory to serve the US market (EUR1.2 million).

They were partially offset by a EUR1.6 million capital gain on property disposals, in particular following the closure of a glass lens plant in Ireland.

Operating Profit

In 2007, operating profit (corresponding to contribution from operations plus or minus other income and expenses from operations and gains and losses on asset disposals) rose 9.6% during the year to EUR504.6 million (17.3% of revenue) from EUR460.5 million (17.1%) in 2006.

Change in operating Reported Like-for-like Effect of
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Essilor Enters Bulgarian Market
2. Essilor Acquires Prescription Laboratories in the United Kingdom and the United States
3. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
4. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
5. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
6. Martek Announces First Quarter 2008 Financial Results
7. HealthFitness Announces 2007 Fourth Quarter and Full-Year Results
8. Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008
9. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
10. Air Methods to Report Fourth Quarter and Fiscal Year 2007 Financial Results on Wednesday, March 12, 2008
11. eDiets.com(R) Announces Q4 and Year End 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... (HealthDay News) -- Prostate cancer patients are more likely ... treatment and die sooner if they also have depression, ... more than 41,200 American men who were diagnosed with ... them through 2009. Nearly 1,900 of the patients had ... their prostate cancer was discovered. "Men with intermediate- ...
(Date:7/11/2014)... Riverside Health System became the first provider of ... late 2012 and now, in partnership with Williamsburg Landing, will ... Williamsburg and Newport News region. , Also known as life ... independent older adults who wish to remain in their homes ... continuing care services as well as control over the cost ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray ... Forecast to 2018", analyzes and studies the major ... Europe, Asia, and the Rest of the World ... growth in the past few years, mainly due ...
(Date:7/11/2014)... best available treatment for patients, from a range of ... taxpayers than the existing clinical trial process, a new ... out while he was a member of the Clinical ... at The University of Manchester,s Health eResearch Centre, published ... today (Friday 11 July) looked at the use of ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 With the ... in men seeking cosmetic surgery and hair transplant procedures, ... such an expansive range of medical tourism destinations, the ... plastic surgery costs and achieve the look they ... renowned as the top name in the medical tourism ...
Breaking Medicine News(10 mins):Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 3
... 3 (HealthDay News) -- The brain,s so-called reward center actually ... experiences causing fear, finds a new study in mice. ... may help explain why some people are thrill-seekers. Pleasurable ... off a bridge, can trigger the production of dopamine, a ...
... discovered that a natural product isolated from a traditional Chinese ... gong teng, and used for hundreds of years to treat ... machinery in the cell. The report, published as a cover ... suggests that the natural product could be a starting ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... of your computer hour after hour may well have its ... include dry, tired eyes, blurred vision, fatigue and headaches. ... but eye experts don,t agree on whether it,s serious or ...
... School of Medicine have found that lactate, a type of ... the formation of long-term memory. These findings have important implications ... memory impairment and diabetes. The research is published in the ... The study is the first to closely evaluate the role ...
... Using recent advances in genomics, researchers have uncovered a genetic ... could help predict which patients are at risk of relapse ... or "turned on" in breast cancer, research led ... several members of the E2F family of genes, which control ...
... cancer, lung cancer, breast cancer or prostate cancer. The study ... by 25 per cent after the cancer diagnosis. , ... and an increased workload that places a strain on one,s ... diagnoses of mental illnesses such as depression. However, there was ...
Cached Medicine News:Health News:Solving a traditional Chinese medicine mystery 2Health News:Solving a traditional Chinese medicine mystery 3Health News:Computer Vision Syndrome: Fact or Fiction? 2Health News:Computer Vision Syndrome: Fact or Fiction? 3Health News:Researchers find new mechanism behind the formation and maintenance of long-term memories 2Health News:Researchers pinpoint genetic pathways involved in breast cancer 2Health News:Cancer patients' partners become ill themselves 2
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... , July 10, 2014   LabStyle ... Management Solution, today announced the appointment of Professor ... member of its Board of Directors. ... and business experience to LabStyle as an entrepreneur, ... legal and corporate governance expert. He currently serves ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Nile Therapeutics,Inc. (Nasdaq: NLTX ), today announced ... failure patient in its Phase IIa, multi-center, open-label,ascending ... candidate,CD-NP, a novel chimeric natriuretic peptide, in development ... The primary objective of the Phase IIa study ...
... 10 Medarex, Inc.,(Nasdaq: MEDX ) today ... in research discovery and antibody development, and the,multiple ... value.,In addition, comprehensive updates on current and future ... were presented by Medarex,s,President and CEO, Howard H. ...
Cached Medicine Technology:Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients 2Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 2Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 5Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 6
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... for applications such as vasectomy that ... ,The autoclavable handpiece with six-foot cord ... cautery electrodes, allowing the physician to ... wide variety of procedures., ,The 2201 ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: